Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - Am Diabetes Assoc
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …
被引用次数：69 相关文章

Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - europepmc.org
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …
[HTML] nih.gov

[HTML][HTML] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - ncbi.nlm.nih.gov
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …

[引用][C] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats

N KARIMIAN, T QIN, HY GAISANO… - … (New York, NY), 2013 - pascal-francis.inist.fr
Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in
Biobreeding Diabetic Rats CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - go.gale.com
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …
[PDF] psu.edu

[PDF][PDF] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - Citeseer
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …
[PDF] researchgate.net

[PDF][PDF] Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats

N Karimian, T Qin, T Liang, M Osundiji, Y Huang… - Diabetes, 2013 - researchgate.net
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter-Regulation in Biobreeding Diabetes-Prone Rats

N Karimian - 2013 - search.proquest.com
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly due to
inadequate pancreatic islet alpha-cell glucagon secretion. We hypothesized that …

Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats

N Karimian, T Qin, T Liang, M Osundiji… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly
attributable to inadequate glucagon secretion. Intra-islet somatostatin (SST) suppression of …

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counter-Regulation in Biobreeding Diabetes-Prone Rats

N Karimian - 2013 - library-archives.canada.ca
Impaired counterregulation during hypoglycemia in type 1 diabetes (T1D) is partly due to
inadequate pancreatic islet alpha-cell glucagon secretion. We hypothesized that …